Gallifen 200 mg/ml suspension for use in drinking water for chickens and pheasants
Gallifen 200 mg/ml suspension for use in drinking water for chickens and pheasants
Authorised
- Fenbendazole
Product identification
Medicine name:
Gallifen 200 mg/ml suspension for use in drinking water for chickens and pheasants
Gallifen 200 mg/ml Suspension zum Eingeben über das Trinkwasser für Hühner und Fasane
Active substance:
- Fenbendazole
Target species:
-
Chicken
-
Pheasant
Route of administration:
-
In drinking water use
Product details
Active substance and strength:
-
Fenbendazole200.00milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for use in drinking water
Withdrawal period by route of administration:
-
In drinking water use
- Chicken
-
Eggs0day
-
Meat and offal8day* when used at 3 mg fenbendazole / kg bw / day
-
Meat and offal6day
-
- Pheasant
-
Eggs0day
-
Meat and offal6dayDo not release pheasants for hunting for at least 6 days after the end of medication.
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP52AC13
Legal status of supply:
-
Medicinal product on medical prescription for renewable delivery
Authorisation status:
-
Valid
Authorised in:
-
Austria
Available in:
-
Austria
Package description:
- White rectangular HDPE bottle of 1 litre with vertically see-through bar with an LDPE insert closed with white PP tamper- evident screw cap with a LDPE sealing disk.
- White rectangular HDPE bottle of 1 litre with vertically see-through bar with an LDPE insert closed with white PP tamper- evident screw cap with a LDPE sealing disk.
- White rectangular HDPE bottle of 1 litre with vertically see-through bar with an LDPE insert closed with white PP tamper- evident screw cap with a LDPE sealing disk.
- White rectangular HDPE bottle of 1 litre with vertically see-through bar with an LDPE insert closed with white PP tamper- evident screw cap with a LDPE sealing disk.
- White rectangular HDPE bottle of 1 litre with vertically see-through bar with an LDPE insert closed with white PP tamper- evident screw cap with a LDPE sealing disk.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
- Biovet J.S.C.
Responsible authority:
- Austrian Agency For Health And Food Safety
Authorisation number:
- 838256
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0579/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
France
-
Germany
-
Greece
-
Hungary
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 11/02/2022
German (PDF)
Published on: 11/10/2021
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 11/10/2021
Labelling
This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 11/10/2021
How useful was this page?: